Showing results (71-80 of 940) with videos related to

Sort By:
Pageof 94
Neurology and Therapy|February 1, 2018
Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case SeriesJacobo Lester, Gerardo Esteban Alvarez-Resendiz, Enrique Klériga, et al.
Neurology and Therapy|December 20, 2018
Treatment Patterns, Healthcare Resource Utilization, and Costs Among Medicare Patients with Multiple Sclerosis in Relation to Disease-Modifying Therapy and Corticosteroid TreatmentMarie Sanchirico, Amanda Caldwell-Tarr, Pallavi Mudumby, et al.
Neurology and Therapy|March 16, 2018
ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregsAdriano Luís Soares De Souza, Stefan Rudin, Rui Chang, et al.
Neurology and Therapy|June 10, 2022
Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease ProcessesTanuja Chitnis, Jo Vandercappellen, Miriam King, et al.
Neurology and Therapy|May 22, 2022
Patterns of Utilization and Expenditure Across Multiple Sclerosis Disease-Modifying Therapies: A Retrospective Cohort Study Using Claims Data from a Commercially Insured Population in the United States, 2010-2019Wen Zhu, Xiaoyu Tang, Rock A Heyman, et al.
Neurology and Therapy|May 24, 2022
A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying TherapiesJeri Burtchell, Daisy Clemmons, Joann Clemmons, et al.
Neurology and Therapy|July 1, 2022
Patient Experience in Early-Stage Parkinson's Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome AssessmentThomas Morel, Sophie Cleanthous, John Andrejack, et al.
Neurology and Therapy|July 2, 2022
Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human StudyValérie Bourdès, Peter Dogterom, André Aleman, et al.
Neurology and Therapy|February 15, 2020
Cladribine Tablets and Relapsing-Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to KnowMohamed AlJumah, Mona Marwan Alkhawajah, Shireen Qureshi, et al.
Neurology and Therapy|March 12, 2020
Current Directions in Deep Brain Stimulation for Parkinson's Disease-Directing Current to Maximize Clinical BenefitAristide Merola, Alberto Romagnolo, Vibhor Krishna, et al.
Pageof 94